Table 2.
Associations between estimated pulmonary artery systolic pressure* and baseline human immunodeficiency virus–hepatitis C virus characteristics, adjusted for age and sex
| Variable | β | 95% CI | P Value |
|---|---|---|---|
| Any drug use | 0.67 | −7.10 to 8.44 | 0.862 |
| Injection drug use (current or past) | −0.20 | −7.37 to 6.97 | 0.955 |
| Time since HIV diagnosis, yr | 0.02 | −0.35 to 0.39 | 0.918 |
| CD4+ cell count | −5.05 | −15.09 to 4.99 | 0.315 |
| HIV viral load detectable | −2.94 | −9.08 to 3.21 | 0.339 |
| ART | 2.34 | −5.36 to 10.04 | 0.542 |
| Time since HCV diagnosis, yr | 0.79 | 0.08 to 1.50 | 0.031 |
| HCV viral load detectable | −1.72 | −7.89 to 4.45 | 0.576 |
| HCV treated | 6.00 | 0.09 to 11.90 | 0.047 |
| IFN treatment | 6.00 | 0.09 to 11.90 | 0.047 |
| Ribavirin treatment | 4.79 | −1.47 to 11.05 | 0.129 |
Definition of abbreviations: ART = antiretroviral therapy; CI = confidence interval; HCV = hepatitis C virus; HIV = human immunodeficiency virus; IFN = interferon.
*
As a continuous measure.